|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,340,000,000 |
Market
Cap: |
116.47(B) |
Last
Volume: |
23,255,346 |
Avg
Vol: |
0 |
52
Week Range: |
$69.43 - $91.38 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 125 |
Guru Rank Value : 7.5 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Medtronic is a medical technology, services and solutions company. Co.'s four operating and reportable segments are as follows: Cardiovascular Portfolio, which is made up of the cardiac rhythm and heart failure, structural heart and aortic, and coronary and peripheral vascular divisions; Medical Surgical Portfolio, which is made up of the surgical innovations and respiratory, gastrointestinal, and renal divisions; Neuroscience Portfolio is made up of the cranial and spinal technologies, specialty therapies, and neuromodulation divisions; and Diabetes Operating Unit, which develops, manufactures, and markets products and services for the management of Type 1 and Type 2 diabetes.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
30,695 |
35,692 |
55,558 |
74,593 |
Total Sell Value |
$2,613,055 |
$3,023,658 |
$4,712,515 |
$6,247,266 |
Total People Sold |
1 |
2 |
5 |
5 |
Total Sell Transactions |
1 |
2 |
7 |
9 |
End Date |
2023-12-28 |
2023-09-26 |
2023-03-28 |
2022-03-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Marinaro Michael |
EVP & President, Surgical OU |
|
2024-03-05 |
4 |
D |
$83.60 |
$47,067 |
D/D |
(563) |
28,779 |
|
- |
|
Salmon Sean |
EVP & President Cardiovascular |
|
2024-02-21 |
4 |
S |
$85.06 |
$2,613,055 |
D/D |
(30,695) |
48,289 |
|
-1% |
|
Salmon Sean |
EVP & President Cardiovascular |
|
2024-02-21 |
4 |
OE |
$62.76 |
$2,120,121 |
D/D |
30,695 |
78,984 |
|
- |
|
Kirk Jennifer M |
Chief Accounting Officer |
|
2024-02-01 |
4 |
D |
$88.09 |
$102,096 |
D/D |
(1,159) |
13,208 |
|
- |
|
Wall Brett A. |
EVP & Pres Neuroscience |
|
2023-12-19 |
4 |
AS |
$82.17 |
$410,603 |
D/D |
(4,997) |
28,910 |
|
1% |
|
Fong Ivan K |
EVP GENERAL COUNSEL & SECR |
|
2023-12-11 |
4 |
D |
$79.35 |
$154,891 |
D/D |
(1,952) |
39,201 |
|
- |
|
Salmon Sean |
EVP & President Cardiovascular |
|
2023-12-08 |
4 |
D |
$79.27 |
$34,482 |
D/D |
(435) |
48,103 |
|
- |
|
Fong Ivan K |
EVP GENERAL COUNSEL & SECR |
|
2023-12-08 |
4 |
D |
$79.27 |
$56,757 |
D/D |
(716) |
40,091 |
|
- |
|
White Robert John |
EVP & Pres. Medical Surgical |
|
2023-12-08 |
4 |
D |
$79.27 |
$29,251 |
D/D |
(369) |
48,410 |
|
- |
|
Wall Brett A. |
EVP & Pres Neuroscience |
|
2023-12-08 |
4 |
D |
$79.27 |
$34,482 |
D/D |
(435) |
33,907 |
|
- |
|
Smith Gregory L |
EVP Global Ops & Supply Chain |
|
2023-08-23 |
4 |
S |
$83.84 |
$838,400 |
D/D |
(10,000) |
46,723 |
|
1% |
|
Wall Brett A. |
EVP & Pres Neuroscience |
|
2023-08-14 |
4 |
AS |
$83.38 |
$83,380 |
D/D |
(1,000) |
33,573 |
|
-3% |
|
Marinaro Michael |
EVP & President, Surgical OU |
|
2023-08-04 |
4 |
AS |
$84.11 |
$113,717 |
D/D |
(1,352) |
28,930 |
|
-5% |
|
Ten Hoedt Rob |
EVP and Pres. Global Regions |
|
2023-08-03 |
4 |
D |
$84.49 |
$342,269 |
D/D |
(4,051) |
52,748 |
|
- |
|
Ten Hoedt Rob |
EVP and Pres. Global Regions |
|
2023-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,251 |
56,799 |
|
- |
|
Martha Geoffrey |
Chairman and CEO |
|
2023-08-03 |
4 |
D |
$84.49 |
$1,517,863 |
D/D |
(17,965) |
141,144 |
|
- |
|
Martha Geoffrey |
Chairman and CEO |
|
2023-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
18,165 |
159,109 |
|
- |
|
Smith Gregory L |
EVP Global Ops & Supply Chain |
|
2023-08-03 |
4 |
D |
$84.49 |
$396,512 |
D/D |
(4,693) |
56,723 |
|
- |
|
Smith Gregory L |
EVP Global Ops & Supply Chain |
|
2023-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,217 |
61,416 |
|
- |
|
Parkhill Karen L |
EVP & Chief Financial Officer |
|
2023-08-03 |
4 |
D |
$84.49 |
$500,096 |
D/D |
(5,919) |
46,327 |
|
- |
|
Parkhill Karen L |
EVP & Chief Financial Officer |
|
2023-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,105 |
52,246 |
|
- |
|
Salmon Sean |
EVP & President Cardiovascular |
|
2023-08-03 |
4 |
D |
$84.49 |
$369,137 |
D/D |
(4,369) |
47,726 |
|
- |
|
Salmon Sean |
EVP & President Cardiovascular |
|
2023-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,604 |
52,095 |
|
- |
|
Wall Brett A. |
EVP & Pres Neuroscience |
|
2023-08-03 |
4 |
D |
$84.49 |
$361,955 |
D/D |
(4,284) |
34,573 |
|
- |
|
Wall Brett A. |
EVP & Pres Neuroscience |
|
2023-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,168 |
38,857 |
|
- |
|
680 Records found
|
|
Page 1 of 28 |
|
|